Cardiology Department, Hospital General Universitario de Castellón, Universitat Jaume I, Castellón, Spain.
Cardiology Department, Hospital Clínico Universitario, INCLIVA, Universitat de València, Valencia, Spain.
ESC Heart Fail. 2019 Oct;6(5):921-926. doi: 10.1002/ehf2.12483. Epub 2019 Jul 19.
Women represent nearly half of the adult heart failure (HF) population and they remain underrepresented in HF studies. We aimed to evaluate the evidence about peak oxygen uptake (peak VO ) for clinical stratification in women with HF. This narrative review summarizes (i) the evidence endorsing the value of cardiopulmonary exercise testing for clinical stratification and phenotyping HF population; (ii) the determinants of a person's functional aerobic capacity to understand predicted values for patients with chronic HF; and (iii) sex differences on peak VO data in different forms of HF. Lastly, based on existing data in patients with HF, we provide a perspective on how to improve existing gaps about the utility of peak VO in clinical stratification in women. Peak VO provides prognosis information in patients with HF; however, its use has been limited for a reduced number of patients excluding women, elderly, and HF patients with preserved ejection fraction. Further studies will help to fill the wide gender gap about the utility of cardiopulmonary exercise testing in the risk assessment and management in women with HF.
女性占心力衰竭(HF)成年患者的近一半,但在 HF 研究中代表性不足。我们旨在评估 HF 女性患者中峰值摄氧量(peak VO )用于临床分层的证据。本综述总结了:(i)心肺运动试验用于临床分层和 HF 人群表型的价值的证据;(ii)理解慢性 HF 患者预测值的个体有氧能力的决定因素;(iii)不同形式 HF 中 peak VO 数据的性别差异。最后,根据 HF 患者的现有数据,我们提供了一种视角,探讨如何改善关于 peak VO 在女性临床分层中效用的现有差距。peak VO 为 HF 患者提供预后信息;然而,由于排除了女性、老年和射血分数保留的 HF 患者,其应用受到限制。进一步的研究将有助于缩小心肺运动试验在 HF 女性风险评估和管理中的效用方面的广泛性别差距。